nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Bimatoprost—AKR1C3—stomach cancer	0.0188	0.794	CrCbGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA5—stomach cancer	0.017	0.108	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—stomach cancer	0.00876	0.0556	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—HRH4—stomach cancer	0.00667	0.0423	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—KISS1R—stomach cancer	0.00519	0.0329	CbGpPWpGaD
Travoprost—Tafluprost—PTGS2—stomach cancer	0.00489	0.206	CrCbGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1R—stomach cancer	0.00464	0.0294	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—F2R—stomach cancer	0.00383	0.0243	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	0.00344	0.0218	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—stomach cancer	0.00342	0.0217	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—KISS1—stomach cancer	0.00334	0.0212	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—stomach cancer	0.00299	0.019	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—RGS2—stomach cancer	0.00287	0.0182	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GAST—stomach cancer	0.00287	0.0182	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—ADRB2—stomach cancer	0.00283	0.0179	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—KISS1R—stomach cancer	0.00262	0.0166	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—stomach cancer	0.00257	0.0163	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—stomach cancer	0.00257	0.0163	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00248	0.0158	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.00221	0.014	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—F2R—stomach cancer	0.00215	0.0137	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—ANXA1—stomach cancer	0.00203	0.0129	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.00193	0.0122	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HRH4—stomach cancer	0.00189	0.012	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.00181	0.0115	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—KISS1—stomach cancer	0.00169	0.0107	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00168	0.0107	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00167	0.0106	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00162	0.0103	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.00154	0.00977	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00152	0.00962	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—KISS1R—stomach cancer	0.00148	0.00938	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00144	0.00915	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00143	0.00905	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00139	0.00881	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KISS1R—stomach cancer	0.00134	0.00852	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00134	0.00851	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.0013	0.00824	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00123	0.00779	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGTR2—stomach cancer	0.0011	0.00697	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—F2R—stomach cancer	0.00109	0.00689	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HRH4—stomach cancer	0.00107	0.00678	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR1A—stomach cancer	0.00106	0.00671	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00105	0.00668	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ANXA1—stomach cancer	0.00102	0.00648	CbGpPWpGaD
Travoprost—Infestation—Epirubicin—stomach cancer	0.00101	0.00123	CcSEcCtD
Travoprost—Infestation NOS—Epirubicin—stomach cancer	0.00101	0.00123	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—stomach cancer	0.00101	0.00123	CcSEcCtD
Travoprost—Palpitations—Capecitabine—stomach cancer	0.001	0.00122	CcSEcCtD
Travoprost—Chest pain—Docetaxel—stomach cancer	0.000995	0.00121	CcSEcCtD
Travoprost—Myalgia—Docetaxel—stomach cancer	0.000995	0.00121	CcSEcCtD
Travoprost—Arthralgia—Docetaxel—stomach cancer	0.000995	0.00121	CcSEcCtD
Travoprost—Asthenia—Irinotecan—stomach cancer	0.00099	0.00121	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ADRB1—stomach cancer	0.000989	0.00628	CbGpPWpGaD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000988	0.00121	CcSEcCtD
Travoprost—Cough—Capecitabine—stomach cancer	0.000987	0.00121	CcSEcCtD
Travoprost—Conjunctivitis—Epirubicin—stomach cancer	0.00098	0.0012	CcSEcCtD
Travoprost—Urinary tract infection—Epirubicin—stomach cancer	0.00098	0.0012	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—stomach cancer	0.000979	0.0012	CcSEcCtD
Travoprost—Hypertension—Capecitabine—stomach cancer	0.000977	0.00119	CcSEcCtD
Travoprost—Hypersensitivity—Fluorouracil—stomach cancer	0.000973	0.00119	CcSEcCtD
Travoprost—Dry mouth—Docetaxel—stomach cancer	0.000973	0.00119	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HRH4—stomach cancer	0.000971	0.00616	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.00097	0.00616	CbGpPWpGaD
Travoprost—Arthralgia—Capecitabine—stomach cancer	0.000963	0.00118	CcSEcCtD
Travoprost—Chest pain—Capecitabine—stomach cancer	0.000963	0.00118	CcSEcCtD
Travoprost—Myalgia—Capecitabine—stomach cancer	0.000963	0.00118	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—stomach cancer	0.00096	0.00117	CcSEcCtD
Travoprost—Anxiety—Capecitabine—stomach cancer	0.00096	0.00117	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000956	0.00117	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—stomach cancer	0.000955	0.00117	CcSEcCtD
Travoprost—Oedema—Docetaxel—stomach cancer	0.000953	0.00116	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—KISS1—stomach cancer	0.000953	0.00605	CbGpPWpGaD
Travoprost—Discomfort—Capecitabine—stomach cancer	0.000951	0.00116	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—stomach cancer	0.000948	0.00116	CcSEcCtD
Travoprost—Infection—Docetaxel—stomach cancer	0.000947	0.00116	CcSEcCtD
Travoprost—Sinusitis—Epirubicin—stomach cancer	0.000946	0.00116	CcSEcCtD
Travoprost—Diarrhoea—Irinotecan—stomach cancer	0.000944	0.00115	CcSEcCtD
Travoprost—Dry mouth—Capecitabine—stomach cancer	0.000942	0.00115	CcSEcCtD
Travoprost—Nervous system disorder—Docetaxel—stomach cancer	0.000935	0.00114	CcSEcCtD
Travoprost—Pruritus—Fluorouracil—stomach cancer	0.000935	0.00114	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—stomach cancer	0.000933	0.00114	CcSEcCtD
Travoprost—Infestation—Doxorubicin—stomach cancer	0.000933	0.00114	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—stomach cancer	0.000932	0.00114	CcSEcCtD
Travoprost—Tachycardia—Docetaxel—stomach cancer	0.000931	0.00114	CcSEcCtD
Travoprost—Skin disorder—Docetaxel—stomach cancer	0.000926	0.00113	CcSEcCtD
Travoprost—Oedema—Capecitabine—stomach cancer	0.000923	0.00113	CcSEcCtD
Travoprost—Bradycardia—Epirubicin—stomach cancer	0.000922	0.00113	CcSEcCtD
Travoprost—Infection—Capecitabine—stomach cancer	0.000917	0.00112	CcSEcCtD
Travoprost—Dizziness—Irinotecan—stomach cancer	0.000912	0.00111	CcSEcCtD
Travoprost—Rhinitis—Epirubicin—stomach cancer	0.000908	0.00111	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—stomach cancer	0.000907	0.00111	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—stomach cancer	0.000907	0.00111	CcSEcCtD
Travoprost—Nervous system disorder—Capecitabine—stomach cancer	0.000905	0.00111	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—stomach cancer	0.000904	0.0011	CcSEcCtD
Travoprost—Diarrhoea—Fluorouracil—stomach cancer	0.000904	0.0011	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—stomach cancer	0.000902	0.0011	CcSEcCtD
Travoprost—Tachycardia—Capecitabine—stomach cancer	0.000901	0.0011	CcSEcCtD
Travoprost—Pharyngitis—Epirubicin—stomach cancer	0.000898	0.0011	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—stomach cancer	0.000898	0.0011	CcSEcCtD
Travoprost—Skin disorder—Capecitabine—stomach cancer	0.000897	0.0011	CcSEcCtD
Travoprost—Urinary tract disorder—Epirubicin—stomach cancer	0.000894	0.00109	CcSEcCtD
Travoprost—Hypotension—Docetaxel—stomach cancer	0.000891	0.00109	CcSEcCtD
Travoprost—Connective tissue disorder—Epirubicin—stomach cancer	0.00089	0.00109	CcSEcCtD
Travoprost—Urethral disorder—Epirubicin—stomach cancer	0.000887	0.00108	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—stomach cancer	0.000878	0.00107	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—stomach cancer	0.000875	0.00107	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—stomach cancer	0.000874	0.00107	CcSEcCtD
Travoprost—Dizziness—Fluorouracil—stomach cancer	0.000874	0.00107	CcSEcCtD
Travoprost—Visual impairment—Epirubicin—stomach cancer	0.000872	0.00107	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—stomach cancer	0.000872	0.00106	CcSEcCtD
Travoprost—Rash—Irinotecan—stomach cancer	0.00087	0.00106	CcSEcCtD
Travoprost—Dermatitis—Irinotecan—stomach cancer	0.000869	0.00106	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000869	0.00106	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000866	0.00549	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KISS1—stomach cancer	0.000865	0.00549	CbGpPWpGaD
Travoprost—Headache—Irinotecan—stomach cancer	0.000864	0.00106	CcSEcCtD
Travoprost—Hypotension—Capecitabine—stomach cancer	0.000863	0.00105	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—stomach cancer	0.000853	0.00104	CcSEcCtD
Travoprost—Dyspnoea—Docetaxel—stomach cancer	0.00085	0.00104	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—stomach cancer	0.000847	0.00104	CcSEcCtD
Travoprost—Eye disorder—Epirubicin—stomach cancer	0.000846	0.00103	CcSEcCtD
Travoprost—Tinnitus—Epirubicin—stomach cancer	0.000844	0.00103	CcSEcCtD
Travoprost—Erythema—Methotrexate—stomach cancer	0.000842	0.00103	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000841	0.00103	CcSEcCtD
Travoprost—Cardiac disorder—Epirubicin—stomach cancer	0.00084	0.00103	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—stomach cancer	0.00084	0.00103	CcSEcCtD
Travoprost—Dyspepsia—Docetaxel—stomach cancer	0.000839	0.00103	CcSEcCtD
Travoprost—Rash—Fluorouracil—stomach cancer	0.000833	0.00102	CcSEcCtD
Travoprost—Dermatitis—Fluorouracil—stomach cancer	0.000832	0.00102	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—stomach cancer	0.000831	0.00102	CcSEcCtD
Travoprost—Headache—Fluorouracil—stomach cancer	0.000828	0.00101	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—stomach cancer	0.000827	0.00101	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—stomach cancer	0.000825	0.00101	CcSEcCtD
Travoprost—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000823	0.00101	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—stomach cancer	0.000823	0.00101	CcSEcCtD
Travoprost—Dyspnoea—Capecitabine—stomach cancer	0.000823	0.00101	CcSEcCtD
Travoprost—Fatigue—Docetaxel—stomach cancer	0.000822	0.001	CcSEcCtD
Travoprost—Angiopathy—Epirubicin—stomach cancer	0.000821	0.001	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—stomach cancer	0.000821	0.001	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—RGS2—stomach cancer	0.000819	0.0052	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GAST—stomach cancer	0.000819	0.0052	CbGpPWpGaD
Travoprost—Nausea—Irinotecan—stomach cancer	0.000819	0.001	CcSEcCtD
Travoprost—Immune system disorder—Epirubicin—stomach cancer	0.000818	0.000999	CcSEcCtD
Travoprost—Mediastinal disorder—Epirubicin—stomach cancer	0.000816	0.000997	CcSEcCtD
Travoprost—Constipation—Docetaxel—stomach cancer	0.000815	0.000996	CcSEcCtD
Travoprost—Pain—Docetaxel—stomach cancer	0.000815	0.000996	CcSEcCtD
Travoprost—Back pain—Methotrexate—stomach cancer	0.000815	0.000995	CcSEcCtD
Travoprost—Dyspepsia—Capecitabine—stomach cancer	0.000813	0.000993	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—stomach cancer	0.000807	0.000986	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ADRB2—stomach cancer	0.000802	0.00509	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000797	0.000974	CcSEcCtD
Travoprost—Fatigue—Capecitabine—stomach cancer	0.000796	0.000972	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—stomach cancer	0.000794	0.000969	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—KISS1R—stomach cancer	0.000793	0.00503	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GLI3—stomach cancer	0.000793	0.00503	CbGpPWpGaD
Travoprost—Mental disorder—Epirubicin—stomach cancer	0.000793	0.000969	CcSEcCtD
Travoprost—Pain—Capecitabine—stomach cancer	0.000789	0.000964	CcSEcCtD
Travoprost—Constipation—Capecitabine—stomach cancer	0.000789	0.000964	CcSEcCtD
Travoprost—Erythema—Epirubicin—stomach cancer	0.000788	0.000963	CcSEcCtD
Travoprost—Feeling abnormal—Docetaxel—stomach cancer	0.000786	0.00096	CcSEcCtD
Travoprost—Nausea—Fluorouracil—stomach cancer	0.000785	0.000959	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—stomach cancer	0.000783	0.000956	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—stomach cancer	0.000781	0.000954	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—stomach cancer	0.000781	0.000954	CcSEcCtD
Travoprost—Gastrointestinal pain—Docetaxel—stomach cancer	0.00078	0.000952	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—stomach cancer	0.000777	0.00095	CcSEcCtD
Travoprost—Dysgeusia—Epirubicin—stomach cancer	0.000772	0.000943	CcSEcCtD
Travoprost—Back pain—Epirubicin—stomach cancer	0.000762	0.000931	CcSEcCtD
Travoprost—Feeling abnormal—Capecitabine—stomach cancer	0.000761	0.000929	CcSEcCtD
Travoprost—Angiopathy—Doxorubicin—stomach cancer	0.00076	0.000928	CcSEcCtD
Travoprost—Malaise—Methotrexate—stomach cancer	0.000759	0.000928	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RBP1—stomach cancer	0.000757	0.0048	CbGpPWpGaD
Travoprost—Immune system disorder—Doxorubicin—stomach cancer	0.000757	0.000924	CcSEcCtD
Travoprost—Vertigo—Methotrexate—stomach cancer	0.000757	0.000924	CcSEcCtD
Travoprost—Gastrointestinal pain—Capecitabine—stomach cancer	0.000755	0.000922	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—stomach cancer	0.000755	0.000922	CcSEcCtD
Travoprost—Abdominal pain—Docetaxel—stomach cancer	0.000754	0.000921	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—RGS2—stomach cancer	0.000744	0.00472	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GAST—stomach cancer	0.000744	0.00472	CbGpPWpGaD
Travoprost—Vision blurred—Epirubicin—stomach cancer	0.000743	0.000907	CcSEcCtD
Travoprost—Cough—Methotrexate—stomach cancer	0.000735	0.000898	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—stomach cancer	0.000734	0.000896	CcSEcCtD
Travoprost—Ill-defined disorder—Epirubicin—stomach cancer	0.000731	0.000893	CcSEcCtD
Travoprost—Abdominal pain—Capecitabine—stomach cancer	0.00073	0.000891	CcSEcCtD
Travoprost—Erythema—Doxorubicin—stomach cancer	0.000729	0.000891	CcSEcCtD
Travoprost—Chest pain—Methotrexate—stomach cancer	0.000717	0.000876	CcSEcCtD
Travoprost—Myalgia—Methotrexate—stomach cancer	0.000717	0.000876	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—stomach cancer	0.000717	0.000876	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—stomach cancer	0.000714	0.000872	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000712	0.00087	CcSEcCtD
Travoprost—Malaise—Epirubicin—stomach cancer	0.000711	0.000868	CcSEcCtD
Travoprost—Discomfort—Methotrexate—stomach cancer	0.000708	0.000865	CcSEcCtD
Travoprost—Vertigo—Epirubicin—stomach cancer	0.000708	0.000865	CcSEcCtD
Travoprost—Back pain—Doxorubicin—stomach cancer	0.000705	0.000862	CcSEcCtD
Travoprost—Hypersensitivity—Docetaxel—stomach cancer	0.000702	0.000858	CcSEcCtD
Travoprost—Palpitations—Epirubicin—stomach cancer	0.000696	0.000851	CcSEcCtD
Travoprost—Cough—Epirubicin—stomach cancer	0.000688	0.00084	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—stomach cancer	0.000687	0.000839	CcSEcCtD
Travoprost—Asthenia—Docetaxel—stomach cancer	0.000684	0.000836	CcSEcCtD
Travoprost—Infection—Methotrexate—stomach cancer	0.000683	0.000834	CcSEcCtD
Travoprost—Hypertension—Epirubicin—stomach cancer	0.00068	0.000831	CcSEcCtD
Travoprost—Hypersensitivity—Capecitabine—stomach cancer	0.00068	0.000831	CcSEcCtD
Travoprost—Ill-defined disorder—Doxorubicin—stomach cancer	0.000677	0.000826	CcSEcCtD
Travoprost—Pruritus—Docetaxel—stomach cancer	0.000675	0.000824	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—stomach cancer	0.000674	0.000823	CcSEcCtD
Travoprost—Chest pain—Epirubicin—stomach cancer	0.000671	0.000819	CcSEcCtD
Travoprost—Myalgia—Epirubicin—stomach cancer	0.000671	0.000819	CcSEcCtD
Travoprost—Arthralgia—Epirubicin—stomach cancer	0.000671	0.000819	CcSEcCtD
Travoprost—Anxiety—Epirubicin—stomach cancer	0.000669	0.000817	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—stomach cancer	0.000668	0.000815	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000666	0.000814	CcSEcCtD
Travoprost—Discomfort—Epirubicin—stomach cancer	0.000663	0.00081	CcSEcCtD
Travoprost—Asthenia—Capecitabine—stomach cancer	0.000662	0.000809	CcSEcCtD
Travoprost—Malaise—Doxorubicin—stomach cancer	0.000658	0.000803	CcSEcCtD
Travoprost—Dry mouth—Epirubicin—stomach cancer	0.000656	0.000801	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—stomach cancer	0.000655	0.0008	CcSEcCtD
Travoprost—Pruritus—Capecitabine—stomach cancer	0.000653	0.000798	CcSEcCtD
Travoprost—Diarrhoea—Docetaxel—stomach cancer	0.000652	0.000797	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—stomach cancer	0.000644	0.000787	CcSEcCtD
Travoprost—Oedema—Epirubicin—stomach cancer	0.000643	0.000786	CcSEcCtD
Travoprost—Hypotension—Methotrexate—stomach cancer	0.000642	0.000784	CcSEcCtD
Travoprost—Infection—Epirubicin—stomach cancer	0.000639	0.00078	CcSEcCtD
Travoprost—Cough—Doxorubicin—stomach cancer	0.000636	0.000777	CcSEcCtD
Travoprost—Diarrhoea—Capecitabine—stomach cancer	0.000632	0.000772	CcSEcCtD
Travoprost—Nervous system disorder—Epirubicin—stomach cancer	0.000631	0.00077	CcSEcCtD
Travoprost—Dizziness—Docetaxel—stomach cancer	0.000631	0.00077	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—stomach cancer	0.00063	0.000769	CcSEcCtD
Travoprost—Tachycardia—Epirubicin—stomach cancer	0.000628	0.000767	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000626	0.000765	CcSEcCtD
Travoprost—Skin disorder—Epirubicin—stomach cancer	0.000625	0.000763	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGTR2—stomach cancer	0.000621	0.00394	CbGpPWpGaD
Travoprost—Myalgia—Doxorubicin—stomach cancer	0.000621	0.000758	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—stomach cancer	0.000621	0.000758	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—stomach cancer	0.000621	0.000758	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—stomach cancer	0.000619	0.000756	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—WWOX—stomach cancer	0.000617	0.00391	CbGpPWpGaD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000616	0.000753	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—F2R—stomach cancer	0.000614	0.0039	CbGpPWpGaD
Travoprost—Discomfort—Doxorubicin—stomach cancer	0.000613	0.000749	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—stomach cancer	0.000613	0.000748	CcSEcCtD
Travoprost—Dizziness—Capecitabine—stomach cancer	0.00061	0.000746	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—stomach cancer	0.000607	0.000742	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—stomach cancer	0.000605	0.000739	CcSEcCtD
Travoprost—Rash—Docetaxel—stomach cancer	0.000601	0.000734	CcSEcCtD
Travoprost—Hypotension—Epirubicin—stomach cancer	0.000601	0.000734	CcSEcCtD
Travoprost—Dermatitis—Docetaxel—stomach cancer	0.000601	0.000734	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—HTR1A—stomach cancer	0.000598	0.00379	CbGpPWpGaD
Travoprost—Headache—Docetaxel—stomach cancer	0.000597	0.00073	CcSEcCtD
Travoprost—Oedema—Doxorubicin—stomach cancer	0.000595	0.000727	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000593	0.000725	CcSEcCtD
Travoprost—Fatigue—Methotrexate—stomach cancer	0.000592	0.000724	CcSEcCtD
Travoprost—Infection—Doxorubicin—stomach cancer	0.000591	0.000722	CcSEcCtD
Travoprost—Pain—Methotrexate—stomach cancer	0.000588	0.000718	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000586	0.000716	CcSEcCtD
Travoprost—Nervous system disorder—Doxorubicin—stomach cancer	0.000584	0.000713	CcSEcCtD
Travoprost—Rash—Capecitabine—stomach cancer	0.000582	0.000711	CcSEcCtD
Travoprost—Dermatitis—Capecitabine—stomach cancer	0.000582	0.00071	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—stomach cancer	0.000581	0.000709	CcSEcCtD
Travoprost—Headache—Capecitabine—stomach cancer	0.000578	0.000706	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—stomach cancer	0.000578	0.000706	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ANXA1—stomach cancer	0.000577	0.00366	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRH4—stomach cancer	0.000573	0.00364	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—WIF1—stomach cancer	0.000573	0.00364	CbGpPWpGaD
Travoprost—Dyspnoea—Epirubicin—stomach cancer	0.000573	0.0007	CcSEcCtD
Travoprost—Nausea—Docetaxel—stomach cancer	0.000566	0.000692	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—stomach cancer	0.000566	0.000692	CcSEcCtD
Travoprost—Dyspepsia—Epirubicin—stomach cancer	0.000566	0.000692	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGTR2—stomach cancer	0.000564	0.00358	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Methotrexate—stomach cancer	0.000562	0.000686	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ADRB1—stomach cancer	0.000559	0.00355	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—F2R—stomach cancer	0.000558	0.00354	CbGpPWpGaD
Travoprost—Hypotension—Doxorubicin—stomach cancer	0.000556	0.000679	CcSEcCtD
Travoprost—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000555	0.000678	CcSEcCtD
Travoprost—Fatigue—Epirubicin—stomach cancer	0.000554	0.000677	CcSEcCtD
Travoprost—Pain—Epirubicin—stomach cancer	0.00055	0.000672	CcSEcCtD
Travoprost—Constipation—Epirubicin—stomach cancer	0.00055	0.000672	CcSEcCtD
Travoprost—Nausea—Capecitabine—stomach cancer	0.000548	0.00067	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—stomach cancer	0.000543	0.000664	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR1A—stomach cancer	0.000543	0.00344	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000542	0.000662	CcSEcCtD
Travoprost—Dyspnoea—Doxorubicin—stomach cancer	0.000531	0.000648	CcSEcCtD
Travoprost—Feeling abnormal—Epirubicin—stomach cancer	0.00053	0.000647	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PRKAB1—stomach cancer	0.000529	0.00336	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000528	0.00335	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Epirubicin—stomach cancer	0.000526	0.000642	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—ANXA1—stomach cancer	0.000524	0.00333	CbGpPWpGaD
Travoprost—Dyspepsia—Doxorubicin—stomach cancer	0.000524	0.00064	CcSEcCtD
Travoprost—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000514	0.000628	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—stomach cancer	0.000513	0.000627	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RNF43—stomach cancer	0.000511	0.00324	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KISS1—stomach cancer	0.000511	0.00324	CbGpPWpGaD
Travoprost—Constipation—Doxorubicin—stomach cancer	0.000509	0.000622	CcSEcCtD
Travoprost—Pain—Doxorubicin—stomach cancer	0.000509	0.000622	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000508	0.00323	CbGpPWpGaD
Travoprost—Abdominal pain—Epirubicin—stomach cancer	0.000508	0.000621	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—ADRB1—stomach cancer	0.000508	0.00322	CbGpPWpGaD
Travoprost—Hypersensitivity—Methotrexate—stomach cancer	0.000506	0.000618	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000502	0.00318	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000502	0.00318	CbGpPWpGaD
Travoprost—Asthenia—Methotrexate—stomach cancer	0.000493	0.000602	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—stomach cancer	0.00049	0.000599	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000487	0.00309	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000487	0.000594	CcSEcCtD
Travoprost—Pruritus—Methotrexate—stomach cancer	0.000486	0.000594	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000474	0.00301	CbGpPWpGaD
Travoprost—Hypersensitivity—Epirubicin—stomach cancer	0.000474	0.000579	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—stomach cancer	0.00047	0.000575	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—stomach cancer	0.00047	0.000574	CcSEcCtD
Travoprost—Asthenia—Epirubicin—stomach cancer	0.000461	0.000564	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—FST—stomach cancer	0.000456	0.00289	CbGpPWpGaD
Travoprost—Pruritus—Epirubicin—stomach cancer	0.000455	0.000556	CcSEcCtD
Travoprost—Dizziness—Methotrexate—stomach cancer	0.000454	0.000555	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ADRB2—stomach cancer	0.000453	0.00287	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HBEGF—stomach cancer	0.000446	0.00283	CbGpPWpGaD
Travoprost—Diarrhoea—Epirubicin—stomach cancer	0.00044	0.000538	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RGS2—stomach cancer	0.00044	0.00279	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GAST—stomach cancer	0.00044	0.00279	CbGpPWpGaD
Travoprost—Hypersensitivity—Doxorubicin—stomach cancer	0.000438	0.000536	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000436	0.00276	CbGpPWpGaD
Travoprost—Rash—Methotrexate—stomach cancer	0.000433	0.000529	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—stomach cancer	0.000433	0.000529	CcSEcCtD
Travoprost—Headache—Methotrexate—stomach cancer	0.000431	0.000526	CcSEcCtD
Travoprost—Asthenia—Doxorubicin—stomach cancer	0.000427	0.000522	CcSEcCtD
Travoprost—Dizziness—Epirubicin—stomach cancer	0.000425	0.000519	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—stomach cancer	0.000421	0.000514	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—FGG—stomach cancer	0.000417	0.00264	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB2—stomach cancer	0.000411	0.00261	CbGpPWpGaD
Travoprost—Nausea—Methotrexate—stomach cancer	0.000408	0.000499	CcSEcCtD
Travoprost—Diarrhoea—Doxorubicin—stomach cancer	0.000407	0.000497	CcSEcCtD
Travoprost—Rash—Epirubicin—stomach cancer	0.000406	0.000495	CcSEcCtD
Travoprost—Dermatitis—Epirubicin—stomach cancer	0.000405	0.000495	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000403	0.00256	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000403	0.00256	CbGpPWpGaD
Travoprost—Headache—Epirubicin—stomach cancer	0.000403	0.000492	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PRKAA1—stomach cancer	0.000401	0.00254	CbGpPWpGaD
Travoprost—Dizziness—Doxorubicin—stomach cancer	0.000394	0.000481	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RBP4—stomach cancer	0.000387	0.00246	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL8—stomach cancer	0.000387	0.00246	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000386	0.00245	CbGpPWpGaD
Travoprost—Nausea—Epirubicin—stomach cancer	0.000382	0.000467	CcSEcCtD
Travoprost—Rash—Doxorubicin—stomach cancer	0.000375	0.000458	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—stomach cancer	0.000375	0.000458	CcSEcCtD
Travoprost—Headache—Doxorubicin—stomach cancer	0.000373	0.000455	CcSEcCtD
Travoprost—Nausea—Doxorubicin—stomach cancer	0.000353	0.000432	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HSPB1—stomach cancer	0.000333	0.00211	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGTR2—stomach cancer	0.000333	0.00211	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BMP2—stomach cancer	0.000329	0.00209	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—F2R—stomach cancer	0.000329	0.00209	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKR1C3—stomach cancer	0.000324	0.00206	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR1A—stomach cancer	0.000321	0.00203	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PRKCB—stomach cancer	0.00031	0.00197	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ANXA1—stomach cancer	0.00031	0.00196	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB1—stomach cancer	0.0003	0.0019	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RPS6—stomach cancer	0.000287	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRKCB—stomach cancer	0.000282	0.00179	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6ST—stomach cancer	0.000281	0.00178	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HBEGF—stomach cancer	0.000263	0.00167	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6R—stomach cancer	0.000251	0.00159	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—RHOA—stomach cancer	0.000249	0.00158	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB2—stomach cancer	0.000243	0.00154	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPP2R1A—stomach cancer	0.000238	0.00151	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—RHOA—stomach cancer	0.000226	0.00144	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SMAD4—stomach cancer	0.000221	0.0014	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL8—stomach cancer	0.000219	0.00139	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FYN—stomach cancer	0.00021	0.00133	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL8—stomach cancer	0.000199	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGFR2—stomach cancer	0.000197	0.00125	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IRS2—stomach cancer	0.00018	0.00114	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CAV1—stomach cancer	0.000175	0.00111	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA1—stomach cancer	0.000175	0.00111	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCB—stomach cancer	0.000167	0.00106	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6ST—stomach cancer	0.000166	0.00105	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APC—stomach cancer	0.000159	0.00101	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK3—stomach cancer	0.000153	0.000968	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6R—stomach cancer	0.000148	0.000939	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK1—stomach cancer	0.000145	0.000921	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EGFR—stomach cancer	0.000145	0.000921	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—stomach cancer	0.000139	0.000881	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SERPINE1—stomach cancer	0.000139	0.000879	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KRAS—stomach cancer	0.000137	0.00087	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RHOA—stomach cancer	0.000134	0.000848	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOS3—stomach cancer	0.000132	0.000839	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—stomach cancer	0.000126	0.0008	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ERBB2—stomach cancer	0.000124	0.000785	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL8—stomach cancer	0.000117	0.000745	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HRAS—stomach cancer	0.000117	0.00074	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN1B—stomach cancer	0.000115	0.000727	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—stomach cancer	0.000112	0.000708	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCND1—stomach cancer	0.000109	0.000694	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUN—stomach cancer	0.000109	0.000692	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—stomach cancer	0.000106	0.000673	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN1A—stomach cancer	0.000106	0.000671	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK8—stomach cancer	0.000103	0.000655	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—stomach cancer	9.53e-05	0.000605	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT3—stomach cancer	9.44e-05	0.000599	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK3—stomach cancer	9.02e-05	0.000572	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—stomach cancer	8.77e-05	0.000556	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK1—stomach cancer	8.58e-05	0.000544	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGFR—stomach cancer	8.58e-05	0.000544	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KRAS—stomach cancer	8.1e-05	0.000514	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—stomach cancer	7.45e-05	0.000472	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TP53—stomach cancer	7.2e-05	0.000457	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRAS—stomach cancer	6.89e-05	0.000437	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—stomach cancer	6.59e-05	0.000418	CbGpPWpGaD
